13F HOLDINGS REPORT
COMMODORE CAPITAL LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001831942-25-000002
Total Value
$1.36B
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 3,874,182 | $162.9M | 11.94% |
| 2 | VAXCYTE INC | PCVX | 1,625,000 | $133.0M | 9.75% |
| 3 | NUVALENT INC | NUVL | 1,621,600 | $126.9M | 9.30% |
| 4 | XENON PHARMACEUTICALS INC | XENE | 2,740,000 | $107.4M | 7.87% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 4,205,000 | $94.6M | 6.93% |
| 6 | VERA THERAPEUTICS INC | VERA | 1,958,600 | $82.8M | 6.07% |
| 7 | SOLENO THERAPEUTICS INC | SLNO | 1,525,000 | $68.5M | 5.02% |
| 8 | ALKERMES PLC | ALKS | 2,300,000 | $66.1M | 4.85% |
| 9 | NURIX THERAPEUTICS INC | NRIX | 3,000,000 | $56.5M | 4.14% |
| 10 | COGENT BIOSCIENCES INC | COGT | 6,881,629 | $53.7M | 3.93% |
| 11 | SPYRE THERAPEUTICS INC | SYRE | 1,988,084 | $46.3M | 3.39% |
| 12 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,400,000 | $46.0M | 3.37% |
| 13 | SCHOLAR ROCK HLDG CORP | SRRK | 950,000 | $41.1M | 3.01% |
| 14 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,218,425 | $37.2M | 2.72% |
| 15 | PHARVARIS N V | PHVS | 1,911,433 | $36.6M | 2.69% |
| 16 | MIND MEDICINE MINDMED INC | 60255C885 | 4,308,425 | $30.0M | 2.20% |
| 17 | ORUKA THERAPEUTICS INC | ORKA | 1,419,714 | $27.5M | 2.02% |
| 18 | CARDIFF ONCOLOGY INC | CRDF | 5,384,616 | $23.4M | 1.71% |
| 19 | INHIBIKASE THERAPEUTICS INC | IKT | 5,925,000 | $19.3M | 1.41% |
| 20 | NEUROGENE INC | NGNE | 800,000 | $18.3M | 1.34% |
| 21 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 500,000 | $18.0M | 1.32% |
| 22 | ORIC PHARMACEUTICALS INC | ORIC | 2,000,000 | $16.1M | 1.18% |
| 23 | APOGEE THERAPEUTICS INC | APGE | 290,000 | $13.1M | 0.96% |
| 24 | ABIVAX SA | AAVXF | 1,284,110 | $9.4M | 0.69% |
| 25 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $7.6M | 0.56% |
| 26 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.3M | 0.38% |
| 27 | CELCUITY INC | CELC | 400,000 | $5.2M | 0.38% |
| 28 | VISTAGEN THERAPEUTICS INC | VTGN | 1,575,000 | $4.6M | 0.34% |
| 29 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $3.6M | 0.26% |
| 30 | THIRD HARMONIC BIO INC | 88427A107 | 237,704 | $2.4M | 0.18% |
| 31 | NKARTA INC | NKTX | 351,848 | $876,102 | 0.06% |